LifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com11-08

Revenue: $313 million, representing 19% year-over-year growth. Profit Margin: 9.8% for the third quarter. Clinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481148420?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 15:14","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481148420","market":"us","top_or_hot":-1,"title":"LifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...","media":"GuruFocus.com","content":"<div>\n<p>Revenue: $313 million, representing 19% year-over-year growth.\nProfit Margin: 9.8% for the third quarter.\nClinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth...</p>\n\n<a href=\"https://finance.yahoo.com/news/lifestance-health-group-inc-lfst-071443550.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-08 15:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/lifestance-health-group-inc-lfst-071443550.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revenue: $313 million, representing 19% year-over-year growth.\nProfit Margin: 9.8% for the third quarter.\nClinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth...</p>\n\n<a href=\"https://finance.yahoo.com/news/lifestance-health-group-inc-lfst-071443550.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFST","symbol_name":"LifeStance Health Group, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/lifestance-health-group-inc-lfst-071443550.html","article_id":"2481148420","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481148420","pubTimestamp":1731050083,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Clinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth.Visit Volumes: 2 million visits, a 15% increase year-over-year.Total Revenue per Visit: Increased 3% year-over-year to $159.Center Margin: $100 million, a 32% increase year-over-year.Adjusted EBITDA: $31 million, a 110% increase year-over-year, representing 9.8% of revenue.Free Cash Flow: $18 million generated in the third quarter.Cash and Debt: $103 million in cash and net long-term debt of $279 million.Days Sales Outstanding : Improved by 2 days to 47 days.Full Year Revenue Guidance: Raised to $1.228 billion to $1.248 billion.Full Year Center Margin Guidance: Raised to $382 million to $398 million.Full Year Adjusted EBITDA Guidance: Raised to $105 million to $115 million.Fourth Quarter Revenue Guidance: $302.5 million to $322.5 million.Fourth Quarter Center Margin Guidance: $89 million to $105 million.GuruFocus has detected 5 Warning Signs with LFST.LifeStance Health Group Inc  reported a r","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LFST":"LifeStance Health Group, Inc."},"translate_title":"LifeStance Health Group Inc(LFST)2024年第三季度收益看涨期权亮点：强劲的收入增长和……","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1},"content_text":"Revenue: $313 million, representing 19% year-over-year growth.\nProfit Margin: 9.8% for the third quarter.\nClinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth.\nVisit Volumes: 2 million visits, a 15% increase year-over-year.\nTotal Revenue per Visit: Increased 3% year-over-year to $159.\nCenter Margin: $100 million, a 32% increase year-over-year.\nAdjusted EBITDA: $31 million, a 110% increase year-over-year, representing 9.8% of revenue.\nFree Cash Flow: $18 million generated in the third quarter.\nCash and Debt: $103 million in cash and net long-term debt of $279 million.\nDays Sales Outstanding (DSO): Improved by 2 days to 47 days.\nFull Year Revenue Guidance: Raised to $1.228 billion to $1.248 billion.\nFull Year Center Margin Guidance: Raised to $382 million to $398 million.\nFull Year Adjusted EBITDA Guidance: Raised to $105 million to $115 million.\nFourth Quarter Revenue Guidance: $302.5 million to $322.5 million.\nFourth Quarter Center Margin Guidance: $89 million to $105 million.\nFourth Quarter Adjusted EBITDA Guidance: $18 million to $28 million.\n\n\nWarning! GuruFocus has detected 5 Warning Signs with LFST.\n\nRelease Date: November 07, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nLifeStance Health Group Inc (NASDAQ:LFST) reported a revenue growth of 19% year-over-year, demonstrating strong financial performance.\nThe company achieved a profit margin of 9.8%, indicating effective cost management and operational efficiency.\nLifeStance Health Group Inc (NASDAQ:LFST) added 285 net clinicians in the third quarter, increasing their total clinician base to over 7,200.\nThe implementation of a new digital patient check-in tool has led to higher patient satisfaction and improved operational efficiencies.\nThe company successfully negotiated rate increases with several payers, mitigating the impact of a rate decrease from a single outlier payer.\n\n Negative Points \n\nLifeStance Health Group Inc (NASDAQ:LFST) faces ongoing challenges with achieving parity in reimbursement rates between mental and physical health services.\nThe company anticipates downward pressure on total revenue per visit due to rate negotiations with a significant payer.\nThere are concerns about the impact of CMS's proposed 3% rate reduction for 2025 on the company's financial performance.\nDespite clinician growth, there is a noted variability in clinician additions throughout the year, with expectations of lower net additions in the fourth quarter.\nThe company is experiencing delays in collections due to payer system updates, impacting days sales outstanding (DSO).\n\n Q & A Highlights \nQ: Ken, can you provide context on the payer engagement team's success in managing rate increases despite the large payer headwind? A: Kenneth Burdick, CEO: The payer engagement team has done an excellent job, securing meaningful rate increases from payers who were below average reimbursement. This has helped offset the impact of the rate decrease from a single outlier payer. The payer environment is positive, but we recognize the challenges payers face, such as higher-than-expected utilization and Medicaid rate disconnects.\nQ: Can you discuss LifeStance's efforts to grow the number of full-time clinicians and the impact on the business? A: Kenneth Burdick, CEO: Our long-term goal is to have most clinicians working full-time. We've implemented incentives to encourage this shift, but progress has been modest. We hire many recent graduates, which helps increase the number of practicing clinicians and aligns them with LifeStance's practices.\nQ: What is your capital allocation strategy going forward, considering your cash balance and long-term debt? A: David Bourdon, CFO: Our primary focus is funding internal growth, such as de novos and technology projects. We also plan to be more acquisitive, using our balance sheet for acquisitions. We do not anticipate paying down debt, given our healthy leverage ratios.\nQ: How are rate negotiations with other payers progressing, given the challenging environment for payers? A: Kenneth Burdick, CEO: We maintain ongoing conversations with payers, which is healthy. The demand for mental health services from employers is a significant lever in these discussions. Although challenging, the conversations remain constructive and productive.\nQ: Can you provide an update on the clinician recruiting environment and any changes in the competitive landscape? A: Kenneth Burdick, CEO: The recruiting environment is stable. We attract clinicians who are entrepreneurial and interested in our compensation model. We continue to see interest from recent graduates and those in smaller practices due to the benefits LifeStance offers, such as professional development and support.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481148420"}